Míriam Potrony

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma

Karla A. Lee, Andrew Maltez Thomas, Laura A. Bolte et al. · Nature Medicine · 2022 · 429 citations · Full text

Life Sciences, Immunology, Microbiology +17

TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma

Klaus Griewank, Rajmohan Murali, Joan Anton Puig‐Butillé et al. · JNCI Journal of the National Cancer Institute · 2014 · 258 citations · Full text

Medicine, Dermatology, Oncology +17

Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma

Johannes R. Björk, Laura A. Bolte, Andrew Maltez Thomas et al. · Nature Medicine · 2024 · 124 citations · Full text

Life Sciences, Microbiology, Oncology +17

Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: Implications for genetic counseling

Míriam Potrony, Joan Anton Puig‐Butillé, Célia Bádenas et al. · Journal of the American Academy of Dermatology · 2014 · 66 citations · Full text

Life Sciences, Genetics, Oncology +16

Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline <i>CDKN2A</i> mutations

Hildur Helgadóttir, Paola Ghiorzo, Remco van Doorn et al. · Journal of Medical Genetics · 2018 · 61 citations · Full text

Medicine, Dermatology, Oncology +17